10. Should those cases when the medicinal product has been placed on the market within the last 3 consecutive years (released in the distribution chain), but it has not been present on the market, be also reported to SÚKL?

Information of this sort is truly essential for the possible application of the sunset clause, and for this reason it should be communicated to SÚKL.